Rubella virus-associated uveitis (RVAU) classically presents with the clinical features of Fuchs uveitis syndrome (FUS). We report a series RVAU, and discuss the relevance of available diagnostic strategies, and how vaccination could potentially prevent disease.
Methods
We retrospectively included patients with RV-positive aqueous humor (AH) with RT-PCR and/or intraocular RV-IgG production, between January 2014 and December 2019. RV-IgG titers from AH and serum were compared with other virus-specific IgG titers (VZV and/or CMV and/or HSV-1), to determine the derived Goldmann-Witmer coefficient (GWC’). Clinical findings at presentation and during follow-up are reported, as well as the anti-RV vaccination status.
Results
All 13 included patients demonstrated intraocular synthesis of RV-IgG (median GWC’: 9.5; 3.2–100). RV-RNA was detected in one patient while PCR results were negative for other HSV1, VZV and CMV. The mean delay in diagnosis was 13 ± 12.6 years, with an initial presentation of FUS in only 3 patients (23%). Only four patients had been vaccinated, but all after the recommended age.
Conclusion
As RVAU is a pleiomorphic entity, virological analysis (RV RT-PCR and GWC’) of aqueous humor is essential to improve the diagnosis and management of this entity. Improper vaccination against RV appears to be implicated in RVAU.
Get full access to this article
View all access options for this article.
References
1.
ChenRMukhopadhyaySMeritsA, et al.ICTV virus taxonomy profile: togaviridae. J Gen Virol2018; 99: 761–762.
BouthryEPiconeOHamdiG, et al.Rubella and pregnancy: diagnosis, management and outcomes. Prenat Diagn2014; 34: 1246–1253.
4.
YazigiADe PecoulasAEVauloup-FellousC, et al.Fetal and neonatal abnormalities due to congenital rubella syndrome: a review of literature. J Matern Fetal Neonatal Med2017; 30: 274–278.
5.
de Groot-MijnesJDde VisserLRothovaA, et al.Rubella virus is associated with Fuchs heterochromic iridocyclitis. Am J Ophthalmol2006; 141: 212–214.
6.
QuentinCDReiberH. Fuchs Heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol2004; 138: 46–54.
7.
Groen-HakanFvan de LaarSvan der Eijk-BaltissenAA, et al.Clinical manifestations, prognosis, and vaccination status of patients with rubella virus-associated uveitis. Am J Ophthalmol2019; 202: 37–46.
8.
SunYJiY. A literature review on Fuchs uveitis syndrome: an update. Surv Ophthalmol2020; 65: 133–143.
9.
BarequetISLiQWangY, et al.Herpes simplex virus DNA identification from aqueous fluid in Fuchs heterochromic iridocyclitis. Am J Ophthalmol2000; 129: 672–673.
10.
CheeSPJapA. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol2008; 146: 883–889.e881.
11.
RuokonenPCMetznerSUcerA, et al.Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs’ heterochromic cyclitis. Graefes Arch Clin Exp Ophthalmol2010; 248: 565–571.
AccorintiMSpinucciGPirragliaMP, et al.Fuchs’ heterochromic iridocyclitis in an Italian Tertiary Referral Centre: epidemiology, clinical features, and prognosis. J Ophthalmol2016; 2016: 1458624.
14.
TappeinerCDreesbachJRoeselM, et al.Clinical manifestation of Fuchs uveitis syndrome in childhood. Graefes Arch Clin Exp Ophthalmol2015; 253: 1169–1174.
15.
Arellanes-GarciaLdel Carmen Preciado-DelgadilloMRecillas-GispertC. Fuchs’ heterochromic iridocyclitis: clinical manifestations in dark-eyed Mexican patients. Ocul Immunol Inflamm2002; 10: 125–131.
16.
TabbutBRTesslerHHWilliamsD. Fuchs’ heterochromic iridocyclitis in blacks. Arch Ophthalmol1988; 106: 1688–1690.
17.
ZareiMDarabeigiSMehrpourM, et al.Fuchs’ uveitis in Iranian patients: a review of 89 eyes. Ocul Immunol Inflamm2019; 27: 1077–1085.
18.
CarnahanMCGoldsteinDA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol2000; 11: 478–483.
19.
Vauloup-FellousC. Standardization of rubella immunoassays. J Clin Virol2018; 102: 34–38.
20.
GoldmannHWitmerR. [Antibodies in the aqueous humor]. Ophthalmologica1954; 127: 323–330.
21.
de BoerJHLuyendijkLRothovaA, et al.Analysis of ocular fluids for local antibody production in uveitis. Br J Ophthalmol1995; 79: 610–616.
22.
ChenSHLinYWGriffithsA, et al.Competition and complementation between thymidine kinase-negative and wild-type herpes simplex virus during co-infection of mouse trigeminal ganglia. J Gen Virol2006; 87: 3495–3502.
23.
WensingBRelvasLMCaspersLE, et al.Comparison of rubella virus- and herpes virus-associated anterior uveitis: clinical manifestations and visual prognosis. Ophthalmology2011; 118: 1905–1910.
24.
ChanNSCheeSPCaspersL, et al.Clinical features of CMV-associated anterior uveitis. Ocul Immunol Inflamm2018; 26: 107–115.
25.
BouchenakiNHerbortCP. Fluorescein angiographic findings and clinical features in Fuchs’ uveitis. Int Ophthalmol2010; 30: 511–519.
RiikonenRS. Retinal vasculitis caused by rubella. Neuropediatrics1995; 26: 174–176.
28.
BabuKAdigaMGovekarSR, et al.Associations of Fuchs heterochromic iridocyclitis in a South Indian patient population. J Ophthalmic Inflamm Infect2013; 3: 14.
29.
ErreraMHGoldschmidtPBatellierL, et al.Findings in detection of Herpesviridae by polymerase chain reaction and intraocular antibody production in a case series of anterior uveitis. Ocul Immunol Inflamm2013; 21: 61–68.
30.
WestenengACRothovaAde BoerJH, et al.Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis. Am J Ophthalmol2007; 144: 781–785.
31.
ErreraMHGoldschmidtPBatellierL, et al.Real-time polymerase chain reaction and intraocular antibody production for the diagnosis of viral versus toxoplasmic infectious posterior uveitis. Graefes Arch Clin Exp Ophthalmol2011; 249: 1837–1846.
32.
WiedbraukDLWernerJCDrevonAM. Inhibition of PCR by aqueous and vitreous fluids. J Clin Microbiol1995; 33: 2643–2646.
33.
GonzalesJAHinterwirthAShanthaJ, et al.Association of ocular inflammation and rubella virus persistence. JAMA Ophthalmol2019; 137: 435–438.
34.
KrepsEODerveauxTDe KeyserF, et al.Fuchs’ uveitis syndrome: no longer a syndrome?Ocul Immunol Inflamm2016; 24: 348–357.
35.
WinchesterSAVargaZParmarD, et al.Persistent intraocular rubella infection in a patient with Fuchs’ uveitis and congenital rubella syndrome. J Clin Microbiol2013; 51: 1622–1624.
36.
SuzukiKSuzukiYMatsumotoM, et al.Expression profile of intravitreous cytokines, chemokines and growth factors in patients with Fuchs heterochromic iridocyclitis. Case Rep Ophthalmol2010; 1: 5–13. 2010/08/26. DOI: 10.1159/000313842.
37.
BirnbaumADTesslerHHSchultzKL, et al.Epidemiologic relationship between Fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Am J Ophthalmol2007; 144: 424–428.
StunfSPetrovecMŽigonN, et al.High concordance of intraocular antibody synthesis against the rubella virus and Fuchs heterochromic uveitis syndrome in Slovenia. Mol Vis2012; 18: 2909–2914.
40.
KleemanKTKieferDJHalbertSP. Rubella antibodies detected by several commercial immunoassays in hemagglutination inhibition-negative sera. J Clin Microbiol1983; 18: 1131–1137.
41.
HeathGDepledgeDPBrownJR, et al.Acute retinal necrosis caused by the zoster vaccine virus. Clin Infect Dis2017; 65: 2122–2125.
42.
AbernathyEPeairsRRChenMH, et al.Genomic characterization of a persistent rubella virus from a case of Fuch' uveitis syndrome in a 73 year old man. J Clin Virol2015; 69: 104–109.
